Has William Petty, MD received payments from drug or device companies?

Yes. Drug and device makers reported $188 in general payments to William Petty, MD across 5 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Petty, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Petty, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Petty, MD

Internal Medicine · Hilton Head Island, SCNPI 1871687665

Payments from drug & device makers

$188in general payments, 2019–2025

Across 5 payments — averaging $37.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biohaven Pharmaceuticals, Inc.$123
Novo Nordisk$35
Radius Health, Inc.$16
Takeda Pharmaceuticals U.S.A., Inc.$14

What the payments were for

Food & beverage$188100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biohaven Pharmaceuticals, Inc.	1	$123
Novo Nordisk	2	$35
Radius Health, Inc.	1	$16
Takeda Pharmaceuticals U.S.A., Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NURTEC ODT$123

How this compares

$188 in reported general payments places this provider in the 40th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina →

Medicare billing

Part B allowed, 2024

$250,566

Medicare patients

412

Services billed

2,672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	98	$132,884
MounjaroTirzepatide	105	$108,149
OzempicSemaglutide	73	$89,907
Repatha SureclickEvolocumab	29	$28,822
JardianceEmpagliflozin	19	$21,837
EntrestoSacubitril/Valsartan	13	$19,225
MyrbetriqMirabegron	18	$18,718
Rosuvastatin Calcium	609	$9,813
SynthroidLevothyroxine Sodium	94	$8,752
Xtampza ErOxycodone Myristate	12	$8,418
Tresiba Flextouch U-200Insulin Degludec	11	$6,549
NexlizetBempedoic Acid/Ezetimibe	12	$5,184
Atorvastatin Calcium	298	$4,416
Incruse ElliptaUmeclidinium Bromide	12	$4,278
Wixela InhubFluticasone Propion/Salmeterol	26	$4,258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$35	$89,90773 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,498 internal medicine providers in South Carolina.

Other internal medicine in Hilton Head Island

William BunnHilton Head Island$125K
Rica SantiagoMt Pleasant$10.7M
Richard MillsMt Pleasant$5.5M
Yvonne DavisMount Pleasant$2.4M
David BolsterSummerville$2.3M
Colby GrossmanSummerville$1.4M
Amit ShahIndian Land$1.4M
Philip NicolMurrells Inlet$782K
Carl SofleyAnderson$673K
Carl MitchellColumbia$564K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →